Category: Service Areas

TOT on DS/DR TB for Doctors NTCC aims to enhance the capacity of the health workers to effectively manage the TB case in their health facilities. In order to develop efficiency of knowledge and skills of Medical Officers/health workers, it intends to provide TOT on DS/DR TB for Doctors to develop the pool of Trainer…

Background and Magnitude of the problem: National Tuberculosis Control Center (NTCC) has been implementing all 6 components of WHO Stop TB Strategy since 2006. The NTP also adopted TB/HIV strategy and policy in 2009. One of the most important and challenging component is TB/HIV as it is needed to coordinate between two programs for effective…

The NTP has identified the following 2 objectives for all research: To improve the quality of caring people with tuberculosis in Nepal. To assist the NTP in planning and implementation of effective TB. Current research includes: Family and Community Volunteer based DOTS research is in progress in the remote hilly areas of Nepal where institutional…

Endorsement of New Stop Strategy as a national policy of NTP by Government of Nepal in 2006, NTP has proposed serial of activities toward engaging private & public health providers to ensure wider provision of standardized diagnosis, treatment and follow-up in line with national protocol. DOTS orientation/training to public/private practitioners, paramedics, nursing, industrial workers, slum…

The Government of Nepal, National Tuberculosis Control Center developed a comprehensive National strategy plan (2010-2015). The New Strategy builds on the previous national strategy and outlines enhanced and more focused commitment for tackling the TB epidemic, consistent with new STOP TB strategy and Millennium Development Goals in line with the Stop TB Partnership targets. NTCC…

TB drug resistance is a major problem that threatens the success of DOTS, the WHO-recommended treatment strategy for detection and cure of TB, as well as global tuberculosis control. Drug resistance arises due to the improper use of durgs in chemotherapy of drug-susceptible TB patients. This improper use is a result of a number of…

In June 2005, WHO’s Strategic, Technical and Advisory Group on TB approved the new Stop TB Strategy.. The new Strategy was addressed to deal with challenges and obstacles that slow the progress in achieving TB control goals. The major identified challenges are the widespread accessibility to quality TB care, TB/HIV co-infection epidemic, multi drug-resistant TB,…